Profile data is unavailable for this security.
About the company
Xiangyu Medical Co Ltd is a China-based company principally engaged in the research, development, production, sales, and service of rehabilitation medical devices. The Company's main products include extracorporeal shock wave therapy devices, piezoelectric shock wave therapy devices, ultrasound therapy devices, pelvic floor functional magnetic stimulation therapy devices, electromyography biofeedback training systems, red light therapy devices. The Company's products cover rehabilitation physiotherapy, rehabilitation training, rehabilitation nursing, rehabilitation aids, rehabilitation assessment, traditional Chinese medicine diagnosis and treatment, and health preservation, and can be used to treat musculoskeletal pain, delayed fractures and avascular necrosis of the femoral head, cervical spondylosis, lumbar disc herniation, degenerative osteoarthritis, and other conditions. The Company mainly conducts its business in the domestic and overseas markets.
- Revenue in CNY (TTM)773.93m
- Net income in CNY73.51m
- Incorporated2002
- Employees2.34k
- LocationXiangyu Medical Co LtdMiddle Section of Diku AvenueNeihuang CountyANYANG 456000ChinaCHN
- Phone+86 3 727776088
- Fax+86 3 727776066
- Websitehttps://www.xyyl.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Runda Medical Technology Co Ltd | 7.40bn | -157.84m | 9.62bn | 3.14k | -- | 2.30 | -- | 1.30 | -0.2609 | -0.2609 | 12.46 | 6.92 | 0.5237 | 3.68 | 1.46 | 2,360,202.00 | -0.5577 | 3.81 | -1.49 | 10.19 | 21.98 | 26.78 | -1.06 | 5.44 | 0.9723 | 1.16 | 0.5605 | 15.85 | -9.13 | 3.34 | -79.77 | -29.14 | -4.52 | -- |
| Shanghai Haohai Biological Tech Co Ltd | 2.52bn | 384.21m | 9.77bn | 2.16k | 27.80 | 1.87 | -- | 3.87 | 1.65 | 1.65 | 10.83 | 24.49 | 0.3512 | 1.53 | 7.84 | 1,169,728.00 | 4.94 | 4.58 | 5.96 | 5.26 | 69.13 | 70.39 | 14.07 | 14.67 | 3.24 | -- | 0.0656 | 42.37 | 1.64 | 10.95 | 1.04 | 2.55 | -1.86 | 14.87 |
| Qingdao Haier Biomedical Co Ltd | 2.26bn | 255.88m | 10.33bn | 2.81k | 40.07 | 2.39 | -- | 4.56 | 0.8144 | 0.8144 | 7.21 | 13.64 | 0.4008 | 4.31 | 5.12 | 806,199.10 | 4.68 | 10.87 | 5.92 | 14.12 | 45.31 | 49.21 | 11.67 | 24.08 | 2.41 | -- | 0.0205 | 28.14 | 0.1288 | 17.67 | -9.71 | 15.03 | -5.53 | 21.16 |
| Xiangyu Medical Co Ltd | 773.93m | 73.51m | 10.92bn | 2.34k | 142.59 | 5.39 | -- | 14.12 | 0.4789 | 0.4789 | 5.07 | 12.67 | 0.2548 | 1.01 | 11.40 | 330,597.70 | 2.35 | 8.54 | 3.26 | 10.17 | 65.98 | 66.78 | 9.22 | 28.37 | 0.9871 | -- | 0.2387 | 32.49 | -0.1717 | 11.71 | -54.68 | -4.41 | 83.55 | -- |
| Shanghai Microport EP MedTech Co Ltd | 458.70m | 52.26m | 11.00bn | 500.00 | 210.45 | 6.14 | -- | 23.98 | 0.111 | 0.111 | 0.9747 | 3.81 | 0.2395 | 1.33 | 6.85 | 917,403.00 | 2.73 | 0.9084 | 2.91 | 0.9579 | 58.24 | 64.95 | 11.39 | 4.09 | 10.17 | -- | 0.0032 | 0.00 | 25.51 | 28.61 | 815.36 | -- | 35.67 | -- |
| Beijing Wandong Medical Technolgy Co Ltd | 1.62bn | 14.41m | 11.10bn | 1.19k | 947.78 | 2.37 | -- | 6.85 | 0.0167 | 0.0167 | 2.26 | 6.66 | 0.2937 | 2.73 | 2.99 | 1,360,016.00 | 0.2623 | 4.51 | 0.304 | 5.21 | 31.59 | 42.82 | 0.8933 | 14.91 | 4.80 | -- | 0.0039 | 43.25 | 23.26 | 9.18 | -16.54 | -1.40 | -1.39 | 21.06 |
| Sansure Biotech Inc | 1.67bn | 271.49m | 11.19bn | 2.35k | 43.62 | 1.57 | -- | 6.70 | 0.4427 | 0.4427 | 2.45 | 12.31 | 0.1852 | 1.04 | 2.46 | 711,687.90 | 2.50 | 21.18 | 2.81 | 24.37 | 73.70 | 68.60 | 13.49 | 40.51 | 4.49 | -- | 0.1716 | 25.74 | 44.78 | 31.89 | -24.23 | 47.50 | 65.28 | -- |
| TINAVI Medical Technologies Co Ltd | 274.20m | -159.01m | 11.43bn | 307.00 | -- | 9.15 | -- | 41.67 | -0.3493 | -0.3493 | 0.6035 | 2.74 | 0.1673 | 2.18 | 7.63 | 893,155.40 | -10.37 | -8.02 | -11.54 | -9.16 | 70.09 | 69.64 | -62.01 | -63.51 | 2.94 | -15.75 | 0.1408 | -- | -14.85 | -4.87 | 22.54 | -- | 12.71 | -- |
| Eyebright Medical Technlgy (Bjng) Co Ltd | 1.48bn | 360.97m | 11.51bn | 2.29k | 31.60 | 4.09 | -- | 7.78 | 1.88 | 1.88 | 7.71 | 14.53 | 0.4048 | 1.89 | 3.34 | 644,799.40 | 9.90 | 10.50 | 11.54 | 12.04 | 62.91 | 75.13 | 24.45 | 31.92 | 3.28 | 24.66 | 0.1753 | 20.11 | 48.24 | 48.51 | 27.77 | 42.25 | 18.40 | -- |
| Shandong Weigao Orthopaedic Devce Co Ltd | 1.48bn | 266.86m | 11.53bn | 2.07k | 43.19 | 2.83 | -- | 7.81 | 0.6672 | 0.6672 | 3.70 | 10.18 | 0.2919 | 0.7798 | 5.17 | 714,278.40 | 5.36 | 9.00 | 6.58 | 11.05 | 64.22 | 74.07 | 18.37 | 24.98 | 4.28 | -- | 0.0011 | 22.90 | 13.18 | -1.59 | 99.22 | -12.72 | -3.40 | -- |
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.47bn | 74.75m | 11.70bn | 2.01k | 151.75 | 3.15 | -- | 7.95 | 0.1647 | 0.1647 | 3.29 | 7.93 | 0.2778 | 1.92 | 2.35 | 730,874.40 | 1.07 | 1.24 | 1.51 | 1.76 | 67.29 | 68.07 | 3.85 | 4.20 | 1.60 | 4.90 | 0.0219 | 0.00 | -0.2705 | 2.71 | -5.73 | 15.09 | -11.35 | -- |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.25bn | 377.82m | 11.95bn | 832.00 | 31.12 | 3.02 | -- | 9.55 | 3.12 | 3.12 | 10.27 | 32.10 | 0.2694 | 1.56 | 3.66 | 1,515,185.00 | 7.94 | 15.38 | 9.10 | 16.87 | 68.10 | 75.38 | 29.45 | 41.85 | 4.36 | -- | 0.0043 | 46.52 | 1.61 | 29.30 | 1.96 | 28.78 | 58.53 | 35.76 |
Data as of Feb 13 2026. Currency figures normalised to Xiangyu Medical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 636.48k | 0.04% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 383.89k | 0.02% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 350.23k | 0.02% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025 | 341.51k | 0.02% |
| Xingyin Fund Management Co., Ltd.as of 30 Jun 2025 | 219.78k | 0.01% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 219.71k | 0.01% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2025 | 196.59k | 0.01% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 177.42k | 0.01% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025 | 172.91k | 0.01% |
| ABC-CA Fund Management Co., Ltd.as of 30 Jun 2025 | 158.27k | 0.01% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
